HAI Solutions Submits QIKCAP® System for FDA Regulatory Review

SAN DIEGO, Calif.--(For Immediate Release )

HAI Solutions, a leader in innovative disinfection technologies, announced today that it has officially submitted the QIKCAP® System for regulatory review by the U.S. Food and Drug Administration (FDA). This milestone represents a significant step forward in the company’s mission to enhance patient safety and reduce the risk of hospital onset bacteremia (HOBs) and microbial contamination (MC).

The QIKCAP® System is a patented, single-use disinfection system designed to protect IV access points from contamination. Engineered for efficiency and ease of use, QIKCAP® helps streamline disinfection protocols, providing an effective, intuitive solution for healthcare providers focused on improving patient outcomes.

“This submission marks a major achievement for our team as we work to deliver a next-generation IV port disinfection solution,” said Nick Perrenoud, CEO of HAI Solutions. “Today marks a pivotal moment in the growth of HAI Solutions. The QIKCAP® submission is not just about a single product; it's a reflection of the incredible talent and hard work of our team, and our commitment to developing life-changing technologies. We believe the QIKCAP® will be a key driver of our future success and we are eager to bring this important innovation to patients as quickly as possible”.

HAI Solutions remains committed to improving clinical outcomes, standardizing clinical workflows and looks forward to working closely with the FDA throughout the regulatory review process.


About HAI Solutions

Based in San Diego CA, HAI Solutions is developing a novel and diverse platform of innovative intravenous therapy solutions targeting IV contamination for the Operating Room, Intensive Care Unit and Emergency Room. We believe in protecting every patient by building innovative medical devices which address the challenges and pitfalls associated with Intravenous Care and Vascular Access. We are advancing clinical care across the healthcare spectrum.

For More Information Contact (Media):
Admin@HAI-Solutions.com

Next
Next

HAI Solutions Secures Landmark International Distribution Agreement